Billionaire Ken Griffin Expands Eli Lilly Position Amid Pharmaceutical Growth Outlook

Citadel founder Ken Griffin nearly quadrupled his holdings in Eli Lilly during the second quarter, signaling strong institutional confidence in the pharmaceutical giant’s pipeline and market trajectory. The aggressive accumulation highlights Wall Street’s continued optimism surrounding the company’s weight-loss and Alzheimer’s drug portfolios.